The 5 steps from technology design to commercialization

Table of Contents
Bringing a technology from the lab to the market goes through five steps: proof of concept, market validation, pilot scale, transfer to manufacturing and marketing. The technical steps must move forward in parallel with the reading of the market, intellectual property and financing. A lot of good technology doesn’t stop because it’s bad: it gets lost between the prototype and the first revenues, in what’s called the valley of death. Progrès Conseils supports innovators in this critical transition, from conception to commercialization.
Having a promising technology is one thing. Bringing it to market is another. Between the discovery and the first sale, each step requires method, evidence, relationships and structuring decisions. Skipping a step or taking it too quickly can jeopardize the project further afield, even when the technology is solid.
Here is the step-by-step process, with common mistakes to avoid and questions to validate before moving on.
Step 1: Proof of concept at laboratory scale
It all starts with demonstrating that the technology works as intended in a controlled environment. Proof of concept validates technical feasibility before committing significant resources to development, equipment, or manufacturing.
It is also the stage where we confirm what is really new, reproducible and potentially protectable. A formulation, process, or device can work once in the lab; The real value comes from understanding the parameters that make it possible to reproduce the result.
This documentation serves both the intellectual property, the financing strategy and, where the work is eligible, the SR&ED file.
Common mistake: confusing a one-time proof with a reproducible proof.
Question to be validated: do we know how to explain why the technology works, within what limits and with what critical parameters?
Step 2: Market validation, in parallel
A technology does not sell itself. Before investing more, it is necessary to assess the real demand, the promising segments, the customer irritants, the existing alternatives and the commercial viability. This step does not come after the technique: it moves forward at the same time.
Validating early avoids the worst-case scenario: a technically successful technology, but without a clear buyer. Market validation transforms intuition into concrete signals: customer conversations, prioritized use cases, available budget, purchase conditions, possible partners and first proofs of interest.
A common mistake is waiting until the technology is ready before talking to the market.
Question to validate: who really has the problem, how much does this problem cost and why would we buy our solution rather than an existing solution?
Step 3: Scaling up
What works in the lab doesn’t automatically work on a larger scale. The transition to piloting, for example in process chemistry, advanced manufacturing or clean technologies, is one of the riskiest moments of the journey.
The goal is to reduce technical risks before errors become too costly: replicate results at a higher volume, measure critical parameters, test process limits, document deviations, and methodically prepare for the next step.
It is often here that the project reveals its real challenges: yield, stability, unit cost, availability of materials, equipment constraints, safety, compliance or production capacity.
A common mistake is to move too quickly from prototype to sales without having validated the robustness of the process.
Question to be validated: what breaks, varies or becomes too expensive when you increase the scale?
Step 4: Technology transfer to manufacturing
Then comes the transition from pilot to industrial production. Technology transfer requires stabilizing the process under real manufacturing conditions and controlling the technical, operational and financial risks associated with the change of scale.
It is a stage of relationships as much as of technique. It is often necessary to mobilize the right manufacturers, partners, equipment manufacturers, suppliers or integrators. The choice of partners directly influences the ability to produce reliably, cost-effectively and compliantly.
To succeed in this transfer, it is to transform a validated prototype into a manufacturable product. It is also documenting technology clearly enough so that it can be produced, transferred, licensed, or defended in a funding discussion.
A common mistake is to treat manufacturing as a simple execution, when it often transforms the product and the business model.
Question to validate: do we have the right partners, the right production parameters and a realistic understanding of unit costs?
Step 5: Marketing
The final step turns technology into revenue. It doesn’t start on launch day: it is prepared throughout the course. Good marketing is based on customer validation, established relationships, technical proof and the ability to produce.
It combines several components:
- Business development : a concrete go-to-market strategy, then its execution.
- Prospecting and networking : connecting technology to the right partners, customers, distributors or industry players.
- Licensing : Assigning or acquiring a license to accelerate development, depending on the strategy chosen.
- Regulatory compliance and intellectual property : two aspects to be secured early, never once the product is ready.
At this stage, the quality of the decisions made in the previous stages often makes the difference between a slow time-to-market and a launch that can generate real revenue.
A common mistake is to believe that technical proof is enough to trigger sales.
Question to validate: do we have a clear value proposition, a market access channel and strong enough evidence to convince the first customers?
The stage that is not on any plan: crossing the valley of death
Between the proof of concept and the first revenues, there is a gap that many technologies never cross. Public funding is becoming less accessible, private capital is waiting for evidence of traction, and scaling up requires significant spending.
Understanding and anticipating this transition is decisive. Three projects must be aligned: financing, validation of the contract and technical execution. This is why the question of financing your innovation project and the commercialization strategy must be thought of together, not separately. We dedicate a dedicated article to it on the valley of the death of innovation.
A course to be managed, not a simple series of stages
Every step you take brings your technology closer to real revenue. Every step that is avoided or botched brings the project closer to a dead end. Good support is based on a double reading: technical rigour to advance the technology, and commercial vision to bring it to market.
Do you have a technology to bring to market? Progrès Conseils can help you situate your project in the pathway, identify the risks of scaling up, clarify financing needs and structure the next steps towards commercialization.
Let’s discuss your marketing strategy : we look at your project together and clarify priority decisions.
What are the steps to commercialize a technology?
There are five main steps: proof of concept at laboratory scale, market validation, scale-up, technology transfer to manufacturing, and then marketing. Market validation, intellectual property and financing must move forward in parallel with the technical steps.
Should the market be validated before or after the proof of concept?
Both approaches benefit from moving forward together. Proof of concept confirms technical feasibility, while market validation confirms demand, use cases, and purchase conditions. It is their convergence that justifies moving to a pilot scale.
What is technology transfer to manufacturing?
This is the transition from pilot to industrial production. This step requires stabilizing the process parameters on a larger scale, mobilizing the right partners and controlling the technical, operational and financial risks associated with the change of scale.
At what stage should you think about intellectual property?
As soon as possible, ideally from the proof of concept and before any public disclosure. A delayed IP strategy can weaken protection, complicate licensing, and reduce the value of innovation in a funding discussion.
Why do some promising technologies never reach the market?
Often because they get stuck between the prototype and the first returns, in the valley of death. The project then has to deal with a funding gap, incomplete market validation and a costly technical leap at the same time.
